HealthEquity, Inc. (NASDAQ:HQY) Shares Sold by Cornercap Investment Counsel Inc.

Cornercap Investment Counsel Inc. cut its stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) by 57.0% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 7,405 shares of the company's stock after selling 9,799 shares during the period. Cornercap Investment Counsel Inc.'s holdings in HealthEquity were worth $606,000 at the end of the most recent quarter.

Other institutional investors also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in HealthEquity by 1.7% in the first quarter. Vanguard Group Inc. now owns 8,768,632 shares of the company's stock worth $715,783,000 after acquiring an additional 149,133 shares during the period. Vaughan Nelson Investment Management L.P. boosted its stake in shares of HealthEquity by 1.8% during the second quarter. Vaughan Nelson Investment Management L.P. now owns 616,860 shares of the company's stock valued at $53,173,000 after purchasing an additional 11,150 shares in the last quarter. Oppenheimer Asset Management Inc. increased its holdings in HealthEquity by 29.4% during the second quarter. Oppenheimer Asset Management Inc. now owns 64,214 shares of the company's stock valued at $5,535,000 after buying an additional 14,573 shares during the period. Diversify Wealth Management LLC purchased a new position in HealthEquity during the second quarter valued at approximately $8,182,000. Finally, Sequoia Financial Advisors LLC bought a new position in HealthEquity in the second quarter worth approximately $1,122,000. Hedge funds and other institutional investors own 99.55% of the company's stock.

Analyst Ratings Changes

A number of research analysts have recently issued reports on the company. Bank of America lifted their price target on HealthEquity from $100.00 to $120.00 and gave the company a "buy" rating in a report on Wednesday. The Goldman Sachs Group began coverage on HealthEquity in a research note on Friday. They issued a "neutral" rating and a $108.00 target price on the stock. JMP Securities reissued a "market outperform" rating and set a $105.00 price target on shares of HealthEquity in a research report on Wednesday, September 4th. BTIG Research lifted their price objective on shares of HealthEquity from $110.00 to $130.00 and gave the stock a "buy" rating in a research report on Thursday. Finally, Royal Bank of Canada reissued an "outperform" rating and set a $92.00 target price on shares of HealthEquity in a research report on Wednesday, September 4th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat.com, HealthEquity has an average rating of "Moderate Buy" and an average price target of $107.23.

HealthEquity Stock Performance

HQY traded up $3.28 on Friday, reaching $98.98. 1,561,907 shares of the stock were exchanged, compared to its average volume of 620,201. The company's 50-day moving average price is $85.02 and its 200 day moving average price is $81.08. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. The firm has a market capitalization of $8.64 billion, a PE ratio of 82.48, a PEG ratio of 1.48 and a beta of 0.52. HealthEquity, Inc. has a fifty-two week low of $62.10 and a fifty-two week high of $101.17.

HealthEquity (NASDAQ:HQY - Get Free Report) last posted its quarterly earnings results on Tuesday, September 3rd. The company reported $0.66 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.50 by $0.16. The company had revenue of $299.93 million during the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a net margin of 9.61% and a return on equity of 9.01%. As a group, sell-side analysts forecast that HealthEquity, Inc. will post 2.27 EPS for the current fiscal year.

Insiders Place Their Bets

In other HealthEquity news, Director Robert W. Selander sold 8,250 shares of the stock in a transaction on Wednesday, October 9th. The shares were sold at an average price of $82.98, for a total transaction of $684,585.00. Following the transaction, the director now directly owns 54,719 shares of the company's stock, valued at $4,540,582.62. This trade represents a 13.10 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, Director Frank Corvino sold 1,247 shares of the stock in a transaction that occurred on Tuesday, October 1st. The shares were sold at an average price of $80.26, for a total value of $100,084.22. Following the transaction, the director now directly owns 4,823 shares of the company's stock, valued at $387,093.98. The trade was a 20.54 % decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 10,536 shares of company stock valued at $884,517. Company insiders own 2.20% of the company's stock.

HealthEquity Profile

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.